Prostacyclin (or PGI2) is a member of the family of lipid molecules known as eicosanoids.\nAs a drug, it is also known as "epoprostenol".[1] The terms are sometimes used interchangeably
Prostacyclin (PGI2) chiefly prevents formation of the platelet plug involved in primary hemostasis (a part of blood clot formation). It is also an effective vasodilator. Prostacyclin's interactions in contrast to thromboxane (TXA2), another eicosanoid, strongly suggest a mechanism of cardiovascular homeostasis between the two hormones in relation to vascular damage.
Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells.
Baker N, O'Meara SJ, Scannell M, Maderna P, Godson C.
J Immunol. 2009 Mar 15;182(6):3819-26.
PMID: 19265161
doi:10.4049/jimmunol.0803175
Z. Papoutsi, E. Kassi, I. Chinou, M. Halabalaki, L. A. Skaltsounis and P. Moutsatsou (2008).
Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483.
British Journal of Nutrition, 2008 Apr, 99 , pp 715-722
PMID: 17916277
doi:10.1017/S0007114507837421